All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
This product is the plasmid containing an encoded anti-RELA DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.
Sub CAT. | DMAb Clone | DMAb Host | Target Species | DMAb Isotype | DMAb Immunogen | |
DMAb-1972-WJ | 112A1021 | Mouse | IgG1, κ | Synthetic peptide corresponding to amino acids 526-539 (GLLSGDEDFSSIAD) of human NF-kB (p65) protein | ||
DMAb-1973-WJ | 14H2 | Mouse | IgG1 | NFkappaB p65 Mouse monoclonal antibody detects endogenous p65 proteins (~65KD) | ||
DMAb-1455-WJ | 4H211 | Mouse | IgG1, κ | Synthetic peptide corresponding to amino acids 526-539 of human NF-kB (p65) protein | ||
DMAb-626-YC | 7G6 | Mouse | Human | IgG | Recombinant human NFKB p65 | |
DMAb-0509-LY | 8G3 | Mouse | Human | IgG, λ | RELA (NP_068810, 432 a.a. ~ 505 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.Immunogen sequence: GEGTLSEALL QLQFDDEDLG ALLGNSTDPA VFTDLASVDN SEFQQLLNQG IPVAPHTTEP MLMEYPEAIT RLVT | |
DMAb-1978-WJ | 93H1 | Rabbit | IgG | |||
DMAb-1979-WJ | D14E12 | Rabbit | IgG | |||
DMAb-1980-WJ | E379 | Rabbit | IgG | |||
DMAb-1983-WJ | L8F6 | Mouse | IgG2b | |||
DMAb-1993-WJ | 14G10A21 | Mouse | IgG2b, κ | Partial human NF-κB p65 recombinant protein (451-551 aa) | ||
DMAb-1995-WJ | 2A12A7 | Mouse | IgG2a | Recombinant protein (~175 amino acids) from the C-terminal portion of human NF-kappa-B (p65) | ||
DMAb-1458-WJ | 2Q2254 | Mouse | Human | IgG3 | Peptide corresponding to human p65 coupled to BSA | |
DMAb-1998-WJ | 340C1a | Mouse | Human | IgG1 | RELA antibody was raised in mouse using recombinant Human V-Rel Reticuloendotheliosis Viral Oncogene Homolog A,Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B-Cells 3, P65 (Avian) | |
DMAb-2003-WJ | 5G6 | Mouse | NFkappaB p65 Mouse monoclonal antibody detects endogenous p65 proteins | |||
DMAb-1215-WJ | 6H7 | Mouse | IgG1 | |||
DMAb-0137-YJ | 7F1 | Mouse | IgG2b | |||
DMAb-2006-WJ | 9B4 | Mouse | IgG | Synthetic Peptide | ||
DMAb-2007-WJ | 9C4 | Mouse | IgG | Recombinant Protein | ||
DMAb-2009-WJ | A-12 | Mouse | ||||
DMAb-2010-WJ | BV706 | Mouse | IgG1 | |||
DMAb-2011-WJ | C22B4 | Rabbit | IgG | |||
DMAb-2012-WJ | D2S3J | Rabbit | ||||
DMAb-2013-WJ | E1Z1T | Mouse | ||||
DMAb-1622-WJ | E-5 | Mouse | ||||
DMAb-2016-WJ | F-6 | Mouse | ||||
DMAb-0130-CN | G-8 | Mouse | ||||
DMAb-2018-WJ | J144-460 | Mouse | Human | IgG1, κ | Phosphorylated Human or Mouse NF-κB p65 Peptide | |
DMAb-2019-WJ | NF-12 | Mouse | IgG1 | Recombinant mouse NF-kB p65 fragment (C-terminal 151 aa) | ||
DMAb-2021-WJ | S-8 | Mouse | IgG1 | NFkB p65 antibody was raised in Mouse using synthetic peptide from human NFkB as the immunogen |
There are currently no customer reviews or questions for Anti-RELA DNA-encoded mAb (DMAb), pVAX1 (DMAb-1971-WJ). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION